Refractory Chronic Cluster Headache Clinical Trial
— MET-ONSOfficial title:
Study of the Cerebral Metabolism in Patients With Refractory Chronic Cluster Headache Treated by Occipital Nerve Stimulation
The occipital nerve stimulation (ONS) is used to treat patients with refractory primary
chronic headache but its mechanism of action (MoA) remains unknown. Different hypothesis
have been suggested in particular a specific action on cerebral generators involved in
different types of primary headaches or a non specific action on pain modulatory network.
The aim of this study, using the chronic cluster headache as a model, is to determine the
changes in cerebral metabolism induced by ONS to precise its MoA in the treatment of primary
chronic headache.
Status | Recruiting |
Enrollment | 15 |
Est. completion date | August 2016 |
Est. primary completion date | July 2016 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - age > 18 years - chronic cluster headache (according to the IHS) - refractory in who a treatment by ONS have been indicated - patient affiliated at social security, - informed consent signed Exclusion Criteria: - contraindication to MRI - contraindication to 18F-FDG PET - women without contraception/pregnant/breast-feeding - patient non-compliant - patient on legal guardianship |
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
France | CHU -Hôpital Gabriel Montpied | Clermont Ferrand | |
France | Institut des Neurosciences | Marseille | |
France | Département d'Evaluation et Traitement de la Douleur - Pôle Neurosciences Cliniques - Centre Hospitalo-Universitaire de Nice | Nice | |
France | Centre d'Urgence Céphalées | Paris |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire de Nice |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Comparison of cerebral metabolism | Changes of cerebral metabolism associated with ONS efficacy | Baseline (before ONS), 1 week after ONS , 3 month after ONS | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04814381 -
Ketamine + Magnesium for Chronic Cluster Headache (KETALGIA)
|
Phase 4 |